Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Phase II trial evaluates belinostat with bortezomib in refractory multiple myeloma

March 30, 2007

Azixa studied in phase II for melanoma patients with brain metastases

March 30, 2007

ABT-888, a new PARP inhibitor, shows antitumor activity in several cancer models

March 30, 2007

BMS-695735: a novel, improved IGF-1R inhibitor reported by BMS

March 30, 2007

Recent patents cover new therapeutic agents for cancer

March 30, 2007

rNAPc2 receives fast track designations in metastatic colorectal cancer

March 29, 2007

Terameprocol studied in phase I/II trial for brain tumors

March 29, 2007

OncoGel studied in phase I/II GBM study

March 29, 2007

Novel antimitotics targeting the kinesin spindle protein presented at the ACS

March 29, 2007

European orphan drug designation for enzastaurin in DLBCL

March 28, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...